[1] Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer [J]. Oral Oncol, 2009,45(4-5):309-316.
[2] Woolgar JA, Triantafyllou A. A histopathological appraisal of surgical margins in oral and oropharyngeal cancer resection specimens [J]. Oral Oncol, 2005,41(10):1034-1043.
[3] Batsakis JG. Surgical excision margins: a pathologist’s perspective[J]. Adv Anat Pathol, 1999,6(3):140-148.
[4] Meier JD, Oliver DA, Varvares MA. Surgical margin determination in head and neck oncology: current clinical practice. The results of an International American Head and Neck Society Member Survey[J]. Head Neck, 2005,27(11):952-958.
[5] Nathan CO, Liu L, Li BD, et al. Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer [J]. Oncogene,1997, 15(5):579-584.
[6] Nathan CO, Amirghahri N, Rice C, et al. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients [J]. Laryngoscope, 2002,112(12):2129-2140.
[7] Nathan CO, Franklin S, Abreo FW, et al. Analysis of surgical margins with the molecular marker eIF4E: a prognostic factor in patients with head and neck cancer [J]. J Clin Oncol, 1999,17(9):2909-2914.
[8] Nathan CO, Amirghahari N, Abreo F, et al. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway [J]. Clin Cancer Res. 2004, 10(17):5820-5827.
[9] Franklin S，Pho T，Abreo FW，et al. Detection of the proto-oncogene eIF4E in larynx and hypopharynx cancers [J]．Arch Otolaryngol Head Neck Surg，1999，125(2)：177-182.
[10] 程进强. eIF4E蛋白在口腔鳞癌手术切缘的表达及意义[J].医学信息，2010，5（4）：740-741.
[11] 雷文斌， 苏振忠， 文卫平，等. 喉癌切缘中eIF4E、p53、ras和c-myc表达与预后的研究[J].中山大学学报：医学科学版，2007,28（5）：545-549.
[12] Palka KT, Slebos RJ, Chung CH. Update in molecular diagnostic tests in head and neck cancer[J]. Semin Oncol, 2008 , 35(3): 198-210.
[13] 余蓉，张怡. eIF4E与恶性肿瘤[J].国际肿瘤学杂志，2006,33（5）：342-343.
[14] 王忠辉，苏树英. eIF4E与肿瘤研究进展[J].医学综述，2008,14（8）：1178-1180.
[15] van Houten VM, Leemans CR, Kummer JA, et al. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study [J]. Clin Cancer Res, 2004 ,10 (11): 3614-3620.
[16] Huang X, Pateromichelakis S, Hills A, et al. p53 mutations in deep tissues are more strongly associated with recurrence than mutation-positive mucosal margins [J]. Clin Cancer Res, 2007, 13(20):6099-6106.
[17] Graveland AP, Golusinski PJ, Buijze M, et al. Loss of heterozygosity at 9p and p53 immunopositivity in surgical margins predict local relapse in head and neck squamous cell carcinoma[J]. Int J Cancer， 2011,128(8):1852-1859.
[18] Tunca B, Erisen L, Coskun H, et al. p53 gene mutations in surgical margins and primary tumor tissues of patients with squamous cell carcinoma of the head and neck [J]. Tumori, 2007, 93(2):182-188.
[19] Bremmer JF, Braakhuis BJ, Brink A, et al. Comparative evaluation of genetic assays to identify oral pre-cancerous fields [J]. J Oral Pathol Med, 2008, 37(10):599-606.
[20] Temam S, Casiraghi O, Lahaye JB, et al. Tetranucleotide microsatellite instability in surgical margins for prediction of local recurrence of head and neck squamous cell carcinoma [J]. Clin Cancer Res, 2004，10(12 Pt 1):4022-4028.
[21] Sardi I, Franchi A, Ferriero G, et al. Prediction of recurrence by microsatellite analysis in head and neck cancer [J]. Genes Chromosomes Cancer, 2000， 29(3):201-206.
[22] Sinha P, Bahadur S, Thakar A, et al. Significance of promoter hypermethylation of p16 gene for margin assessment in carcinoma tongue [J] . Head Neck, 2009,31(11):1423-1430.
[23] Martone T, Gillio-Tos A, De Marco L, et al. Association between hypermethylated tumor and paired surgical margins in head and neck squamous cell carcinomas [J]. Clin Cancer Res, 2007, 13(17):5089-5094.
[24] Tan HK, Saulnier P, Auperin A, et al. Quantitative methylation analyses of resection margins predict local recurrences and disease-specific deaths in patients with head and neck squamous cell carcinomas [J]. Br J Cancer, 2008, 99(2):357-363. |